OncoMatch/Clinical Trials/NCT05796375
Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
Is NCT05796375 recruiting? Yes, currently enrolling (May 2026). This Phase 2 trial studies non-drug interventions for non-muscle-invasive bladder cancer.
The purpose of this research is to determine whether bladder cancer monitoring can be improved by replacing some cystoscopy procedures with urine testing. Specifically, this study examines whether there are any differences in urinary symptoms, discomfort, number of invasive procedures, anxiety, complications, cancer recurrence or cancer progression when some cystoscopy procedures are replaced with urine testing.
Check if I qualifyExtracted eligibility criteria
Cancer type
Urothelial Carcinoma
Disease stage
Grade: low grade
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- West Haven VA Medical Center · West Haven, Connecticut
- Bay Pines VA Healthcare System · Bay Pines, Florida
- VA Boston Jamaica Plains Campus · West Roxbury, Massachusetts
- VA St.Louis Healthcare System · St Louis, Missouri
- University Hospitals Cleveland Medical Center · Cleveland, Ohio
Showing up to 5 US sites. See all sites on ClinicalTrials.gov →
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify